Skip to main content
Loading
Access My Account to renew your membership
Dismiss
About/Contact
Branches
Foundation
Journal (CJHP)
Advertising
Create Account
Cart
Toggle search
Toggle navigation
Keyword Search
Sign In
Resources
Toggle
Equity, Diversity, Inclusion, and Accessibility
COVID-19
Official Publications
Position Statements
Canadian Medication Optimization Briefing
Guidelines
Information Papers
Annual Reports
Clinical Pharmacy Key Performance Indicators
Guide for Writers and Reviewers
Archived Official Publications
Compounding
Compounding Briefing Series
Assessment Tool for Aseptic Compounding
Shared Resources
Adoption of Model Standards
Frequently Asked Questions
Other
Hospital Pharmacy in Canada Survey
HPC Survey Board
HPCS Sponsors
HPCS Report Archives
Clinical Pharmacy Archives
Discharge Medication Management Toolkit
RxFiles Members Access
Bookstore
Glossary
Glossaire
Blinding Guidelines
About/Contact
Toggle
External Representation
Board Executive Nominations
Task Forces
Affiliated Boards
Committees
Board
Staff
CSHP Representative
Professional Development
Toggle
CSHP Webinars
Clinical Pharmacy Webinars
Compounding Webinars
Medication System Webinars
Past PPC Sessions
Pharmacy 365 Webinars
Events
Events Code of Conduct Policy
Hospital Pharmacy 101
Grants
Pharmacy Residency Application Roadmap
Professional Practice Conference 2024
Together 2023
Together 2022
Banff Seminar
Harrison Hospital Pharmacy Management Seminar
News
Toggle
All news
CSHP e-Newsbrief
Advocacy
Toggle
Pharmacy Appreciation Month
Drug Shortages
Pharmacare
Medical Assistance in Dying
Opioid Crisis
Adverse Drug Reactions and MDIs
Prescribing
Advocacy Toolkit
Other
Interprofessional Practice Models
Management Leadership
Special Access Programme
Methadone Prescribing
Drug Distribution
Medication Incidents
Medication Labelling
Consultations
Draft Guidance: Accelerated Review of Human Drug Submissions
Proposed changes to the Special Access Program
Changes to the scheduling of tramadol
Health Canada proposes changes to drug regulations with respect to pharmacy practice
Pilot: Education to support mandatory reporting of serious ADR and MDI (Vanessa’s Law)
Proposed Amendments to Canada’s Food and Drug Regulations to Require the Reporting of Serious Advers
Monitoring of Medical Assistance in Dying Regulations
Advocacy Enquiries
Residency
Member Centre
Toggle
My Account
Membership Types & Fees
Renew Your Membership
Join CSHP
Benefits
Membership Referral
CSHP and A.P.E.S. Strategic Alliance
Industry Supporter
Hospital & Not-for-Profit Supporters
Liability Insurance
Recognition
Awards
Honorary Membership
Membership Milestones
Fellows Program
Pharmacy Jobs
Pharmacy Specialty Networks
About PSNs
Participating in a PSN
Suggesting a new PSN
PSN Chair Resource Centre
Conducting Surveys and Research via a PSN
Volunteering
Member & Supporter Directory
Membership and Brand Materials
My Account
Home
»
Resources
»
Glossaire
The requested content could not be loaded.
Resources
Equity, Diversity, Inclusion, and Accessibility
COVID-19
Official Publications
Position Statements
Canadian Medication Optimization Briefing
Guidelines
Information Papers
Annual Reports
Clinical Pharmacy Key Performance Indicators
Guide for Writers and Reviewers
Archived Official Publications
Archived Position Statements
Archived Information Papers
Archived Standards and Guidelines
Compounding
Compounding Briefing Series
Assessment Tool for Aseptic Compounding
Shared Resources
Adoption of Model Standards
Frequently Asked Questions
Other
Building a Culture of Safety for Compounding
Service Suppliers
Standards and Guidelines
Hospital Pharmacy in Canada Survey
HPC Survey Board
HPCS Sponsors
HPCS Report Archives
Clinical Pharmacy Archives
Discharge Medication Management Toolkit
RxFiles Members Access
Bookstore
Glossary
Glossaire
Blinding Guidelines
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##